Frontlight ResearchEarly access
What researchers published on Amyloidosis
11,961 papers, newest first.
Showing 20 of 242
Trial resultUsing dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study.PloS one
In plain wordsRead moreRead the paper on PubMedTrial resultSafety and tolerability of anselamimab in participants with light chain amyloidosis: Results from a phase 2 study.European journal of cancer (Oxford, England : 1990)
In plain wordsRead moreRead the paper on PubMedRandomised trialEffect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.Journal of the American College of Cardiology
In plain wordsRead moreRead the paper on PubMedRandomised trialInfluence of Disease-Modifying Therapy on the Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis.Journal of the American College of Cardiology
In plain wordsRead moreRead the paper on PubMedRandomised trialRight Ventricular Function, Clinical Outcomes, and Effect of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: Secondary Analysis of the HELIOS-B Randomized Clinical Trial.JAMA cardiology
In plain wordsRead moreRead the paper on PubMedRandomised trialLeft Atrial Structure and Function, Clinical Outcomes, and Efficacy of Vutrisiran in Transthyretin Amyloidosis With Cardiomyopathy: A Secondary Analysis of the HELIOS-B Randomized Clinical Trial.JAMA cardiology
In plain wordsRead moreRead the paper on PubMedTrial resultA phase 2 trial of daratumumab monotherapy for patients with newly diagnosed cardiac stage IIIb AL amyloidosis.Blood
In plain wordsRead moreRead the paper on PubMedTrial resultDesign and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Randomised trialLong-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extension.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
In plain wordsRead moreRead the paper on PubMedRandomised trialBaseline characteristics of patients with transthyretin amyloid cardiomyopathy in the CARDIO-TTRansform trial of eplontersen.European journal of heart failure
In plain wordsRead moreRead the paper on PubMedRandomised trialEfficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
In plain wordsRead moreRead the paper on PubMedRandomised trialVutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis.Clinical pharmacokinetics
In plain wordsRead moreRead the paper on PubMedRandomised trialVutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy and Renal Impairment: Analyses From HELIOS-B.Journal of cardiac failure
In plain wordsRead moreRead the paper on PubMedRandomised trialAcoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.Journal of cardiac failure
In plain wordsRead moreRead the paper on PubMedRandomised trialDaratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.Blood
In plain wordsRead moreRead the paper on PubMedRandomised trialRationale and Design of CARDIO-TTRansform, a Phase 3 Trial of Eplontersen in Transthyretin Amyloid Cardiomyopathy.Circulation. Heart failure
Randomised trialEplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.Muscle & nerve
In plain wordsRead moreRead the paper on PubMedTrial resultB -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.Journal of the American Society of Nephrology : JASN
In plain wordsRead moreRead the paper on PubMedRandomised trialEffect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO-TTRansform Trial.European journal of neurology
In plain wordsRead moreRead the paper on PubMedRandomised trialLong-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial.JAMA cardiology
In plain wordsRead moreRead the paper on PubMed